Galectin Therapeutics Inc: which funds bought and sold
Institutions that bought and sold Galectin Therapeutics shares in Q2 2026, from the holdings they reported to the SEC on Form 13F for March 31, 2026 and June 30, 2026.
Between March 31, 2026 and June 30, 2026, 51 institutions that filed 13F reports for both quarters added to or opened positions in Galectin Therapeutics, and 43 cut or closed them. Together they added a net 1.8M shares, +13.2% on what they held at the start of the quarter. Active managers and hedge funds on our list were net sellers of 1.9M shares (−55.6%); index fund managers were net buyers of 4.2M shares (+101.8%). 19 opened a new position and 20 sold out entirely.
Bought, Q2 2026 51 institutions, 19 of them new holders Sold, Q2 2026 43 institutions, 20 of them sold out
Net change, all compared +1.8M shares (+13.2%)
Net change, active managers −1.9M shares (−55.6%), 3 bought, 10 sold
Buyers versus sellers
51 bought 23 43 sold
Active managers and hedge funds 3 bought · 10 sold · −1.9M
Index fund managers 9 bought · 0 sold · +4.2M
Other institutions 39 bought · 33 sold · −472K
Biggest buyers
| Institution | Change in shares | Shares June 30, 2026 | Value |
|---|---|---|---|
| Blackrock, Inc. Index funds | +2.2M +273.9% | 3.0M | $13.9M |
| Geode Capital Management, LLC Index funds | +696K +113.5% | 1.3M | $6.1M |
| Vanguard Portfolio Management LLC Index funds | +328K New position | 328K | $1.5M |
| State Street Corp Index funds | +309K +119.7% | 568K | $2.6M |
| Northern Trust Corp Index funds | +256K +196.3% | 387K | $1.8M |
| Vanguard Capital Management LLC Index funds | +202K +10.2% | 2.2M | $10.1M |
| National Bank Of Canada | +168K New position | 168K | $779,056 |
| Cambridge Investment Research Advisors, Inc. | +133K +103.1% | 261K | $1.2M |
| Bank Of New York Mellon Corp | +106K New position | 106K | $490,644 |
| Charles Schwab Investment Management Inc Index funds | +86K +288.0% | 116K | $540,207 |
| Osaic Holdings, Inc. | +81K +7.2% | 1.2M | $5.6M |
| Nuveen, LLC | +64K New position | 64K | $295,614 |
| Vanguard Fiduciary Trust Co Index funds | +62K +20.5% | 366K | $1.7M |
| Gsa Capital Partners LLP | +57K +80.1% | 129K | $597,000 |
| Rhumbline Advisers Index funds | +48K New position | 48K | $224,257 |
| Deutsche Bank Ag\ | +47K New position | 47K | $219,950 |
| Wells Fargo & Company | +40K +641.2% | 47K | $216,646 |
| Commonwealth Equity Services, LLC | +40K +10.9% | 407K | $1.9M |
| UBS Group AG | +40K +22.0% | 219K | $1M |
| Price T Rowe Associates Inc Active manager | +39K New position | 39K | $183,000 |
| Institution | Change in shares | Shares June 30, 2026 | Value |
|---|---|---|---|
| Price T Rowe Associates Inc Active manager | +39K New position | 39K | $183,000 |
| Alliancebernstein L.P. Active manager | +11K New position | 11K | $31,248 |
| FMR LLC Active manager | +154 +1.2% | 13K | $60,972 |
Biggest sellers
| Institution | Change in shares | Shares June 30, 2026 | Value |
|---|---|---|---|
| Millennium Management LLC Hedge fund | −763K −95.5% | 36K | $166,404 |
| Marshall Wace, LLP Hedge fund | −389K −31.9% | 831K | $3.9M |
| Susquehanna International Group, LLP | −379K −68.1% | 177K | $822,194 |
| Debussy Capital Management LP | −259K Sold out | 0 | — |
| Jane Street Group, LLC | −195K Sold out | 0 | — |
| 683 Capital Management, LLC Hedge fund | −162K Sold out | 0 | — |
| Two Sigma Investments, LP Hedge fund | −149K −31.9% | 318K | $1.5M |
| Qube Research & Technologies Ltd Hedge fund | −126K Sold out | 0 | — |
| Goldman Sachs Group Inc | −110K −59.6% | 75K | $345,931 |
| Renaissance Technologies LLC Hedge fund | −105K −70.7% | 43K | $201,112 |
| Barclays PLC | −100K −89.6% | 12K | $53,718 |
| Belpointe Asset Management LLC | −92K −86.7% | 14K | $65,605 |
| Fortis Capital Advisors, LLC | −92K −86.7% | 14K | $65,605 |
| Citadel Advisors LLC Hedge fund | −92K −31.6% | 199K | $921,973 |
| Hudson Bay Capital Management LP Hedge fund | −75K Sold out | 0 | — |
| HRT Financial LP | −51K Sold out | 0 | — |
| &Partners | −41K Sold out | 0 | — |
| Brevan Howard Capital Management LP Hedge fund | −36K Sold out | 0 | — |
| Omers Administration Corp | −24K Sold out | 0 | — |
| Catalyst Funds Management Pty Ltd | −23K Sold out | 0 | — |
| Institution | Change in shares | Shares June 30, 2026 | Value |
|---|---|---|---|
| Millennium Management LLC Hedge fund | −763K −95.5% | 36K | $166,404 |
| Marshall Wace, LLP Hedge fund | −389K −31.9% | 831K | $3.9M |
| 683 Capital Management, LLC Hedge fund | −162K Sold out | 0 | — |
| Two Sigma Investments, LP Hedge fund | −149K −31.9% | 318K | $1.5M |
| Qube Research & Technologies Ltd Hedge fund | −126K Sold out | 0 | — |
| Renaissance Technologies LLC Hedge fund | −105K −70.7% | 43K | $201,112 |
| Citadel Advisors LLC Hedge fund | −92K −31.6% | 199K | $921,973 |
| Hudson Bay Capital Management LP Hedge fund | −75K Sold out | 0 | — |
| Brevan Howard Capital Management LP Hedge fund | −36K Sold out | 0 | — |
| Engineers Gate Manager LP Hedge fund | −19K Sold out | 0 | — |
New positions
| Institution | Shares | Value June 30, 2026 |
|---|---|---|
| Vanguard Portfolio Management LLCIndex funds | 328K | $1.5M |
| National Bank Of Canada | 168K | $779,056 |
| Bank Of New York Mellon Corp | 106K | $490,644 |
| Nuveen, LLC | 64K | $295,614 |
| Rhumbline AdvisersIndex funds | 48K | $224,257 |
| Deutsche Bank Ag\ | 47K | $219,950 |
| Price T Rowe Associates IncActive manager | 39K | $183,000 |
| Metlife Investment Management, LLC | 29K | $133,980 |
| Mirae Asset Global Etfs Holdings Ltd. | 22K | $102,386 |
| Xtx Topco Ltd | 14K | $66,918 |
Sold out
| Institution | Shares | Value March 31, 2026 |
|---|---|---|
| Debussy Capital Management LP | 259K | $721,449 |
| Jane Street Group, LLC | 195K | $543,681 |
| 683 Capital Management, LLCHedge fund | 162K | $453,330 |
| Qube Research & Technologies LtdHedge fund | 126K | $352,765 |
| Hudson Bay Capital Management LPHedge fund | 75K | $208,491 |
| HRT Financial LP | 51K | $142,000 |
| &Partners | 41K | $114,390 |
| Brevan Howard Capital Management LPHedge fund | 36K | $99,282 |
| Omers Administration Corp | 24K | $67,239 |
| Catalyst Funds Management Pty Ltd | 23K | $62,775 |
Who holds the shares
- Institutions reporting
- 98
- Ten largest holders
- 69.4% of 13F-reported shares
- Index fund managers
- 52.5% of 13F-reported shares
- Active managers and hedge funds
- 9.4% of 13F-reported shares
| Type | Bought | Sold | New | Sold out | Net change in shares | Net % |
|---|---|---|---|---|---|---|
| Active managers and hedge funds | 3 | 10 | 2 | 5 | −1.9M | −55.6% |
| Index fund managers | 9 | 0 | 2 | 0 | +4.2M | +101.8% |
| Other institutions | 39 | 33 | 15 | 15 | −472K | −7.3% |
← Back to Galectin Therapeutics Inc · Insiders · Politicians